Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

National Institutes of Health

Federal funding opportunity PAR-25-184 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.